about
Unanticipated antigens: translation initiation at CUG with leucineBroad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICBAssembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia virusesMolecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunizationMULTIPRED: a computational system for prediction of promiscuous HLA binding peptides.PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse.Structure of a pheromone receptor-associated MHC molecule with an open and empty grooveTargeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapyCoronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specificConformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificityCrystal Structures of HLA-A*0201 Complexed with Melan-A/MART-1 26(27L)-35 Peptidomimetics Reveal Conformational Heterogeneity and Highlight Degeneracy of T Cell RecognitionA Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen MicropolymorphismStructural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell EpitopesCrystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding grooveAnalysis of successful immune responses in persons infected with hepatitis C virusImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseImmunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residueHierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.Molecular cloning of a macrophage-derived, interferon-inducible secreted immunoglobulin-binding protein.Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survival.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesInduction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptideHotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes.ER stress affects processing of MHC class I-associated peptides.Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape.Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen.The proteasome activator 11 S REG (PA28) and class I antigen presentationDual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface."Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components.Evolutionary history of the cancer immunity antigen MAGE gene family.Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicityRole of heat shock proteins in protection from and pathogenesis of infectious diseases.
P2860
Q21146394-1DE11A8F-CCE1-4249-8C8E-183042C0F274Q22009950-BC5D5DBC-C4EF-4A0E-B926-A489591969EBQ24337428-B7F9B65C-DB1F-4A22-A670-786FF01677FAQ24562414-16A83D51-A430-446A-96F7-4DE06B4AC9A1Q24676991-28271D18-8B71-4420-BA3E-FC30C0ABDBD6Q24813031-886F1C6D-D049-4B7B-B879-51AE38E0A2D9Q24813312-1917D4C7-6B89-4814-92C6-34E9CA97F3E3Q24816484-AF732102-1B46-40CA-9C50-ED8B9D491495Q26991589-C7D0856D-F2D0-4F67-9C66-D0C012245F17Q27485104-8996EEE9-A90C-44C2-B783-844A043D16C2Q27653583-03F0A117-0A99-4835-97F5-DB30C517E896Q27664235-A76AABAC-E58A-4A85-B717-2B38EBED78BDQ27683527-0B57CA82-E9EF-4199-ABB4-4604893B3081Q27683638-5D6EC925-1589-42A4-98E1-DA5405F79825Q27729958-9A021EC6-D761-4EF6-9CE6-43E0B1A9FEA7Q27860698-0CAB9C72-D4F8-438B-B628-DC464CBD4DDEQ28238379-C5F2C15F-3719-4086-9588-37C67E6D1F25Q28301672-218A423A-FA6A-4195-83C4-B6B83A30904FQ30452573-12E8D4C8-36E7-4321-ADC1-5929AD215C5CQ30452613-8E239FD0-A5DA-4F14-B5DB-3180DB30E97CQ30452642-7C4931E2-4F8D-4CC3-AAA5-08E7EF33E812Q30468546-CEB979AC-2D9C-4F08-91B1-2F1E02E6429AQ30685494-1C0A79BF-04B6-4AAE-9A70-3EA7CFCEBCA9Q30700012-2C6D3B5E-FF15-4400-8BFF-C610115F9C26Q30708754-19DB9CD8-B1E2-49BA-A003-FD5648F2DE81Q30843475-109D9825-B98F-4EDE-9779-63C2C7BB0A34Q33248961-04E86EB3-E015-41D9-8C8C-902BAB4C860CQ33307523-5742C855-326B-4085-8611-4E993C57DEDFQ33322206-3B2C8C5E-0185-40DC-8A9B-EC92EC4E680AQ33409763-9FEE77E4-814D-4500-BCE5-BC5720F659C5Q33683425-B753BA0F-5024-4800-A35D-05D88D11639DQ33782034-5A29E2C2-189E-4AED-A073-2121F3470757Q33788075-C3A5866C-EFC8-44BA-A49C-92FF3899B397Q33796158-73F01783-34BF-44DA-A150-BF9332E7A835Q33894929-2D7C4394-A1CE-4924-9B06-E3B1B290AC9BQ33927547-1C335701-2CD0-474C-9CCA-2D48157AE6C3Q33930580-3F607A45-461E-47C8-8BB7-05DDC45C9412Q33939709-31657EC0-1F5F-477F-96CF-DBFDBADB93A0Q33952895-58E2634E-9499-461C-9D62-29B90FA93065Q33975393-3BA915FF-C916-4AFE-8332-E8308948345A
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Peptides naturally presented by MHC class I molecules.
@en
type
label
Peptides naturally presented by MHC class I molecules.
@en
prefLabel
Peptides naturally presented by MHC class I molecules.
@en
P2093
P1476
Peptides naturally presented by MHC class I molecules.
@en
P2093
P304
P356
10.1146/ANNUREV.IY.11.040193.001241
P577
1993-01-01T00:00:00Z